RxDoctor Payments Data

Kelsey O'Mara, PA

Physician Assistant · Louisville, KYNPI 1376871426

Payments from drug & device makers

$5,553in general payments, 2019–2025

Across 138 payments — averaging $40.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Boston Scientific$840
  • AbbVie$536
  • Si-bone, Inc.$392
  • Relievant Medsystems, Inc.$333
  • Amgen$308
  • plus $959 from 15 others

What the payments were for

  • Travel & lodging$53210%
  • Food & beverage$5,02290%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,553 in reported general payments places this provider in the 90th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$99,618
Medicare patients
219
Services billed
1,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant13$15,107
MovantikNaloxegol Oxalate15$12,074
Pregabalin235$8,235
Gabapentin583$7,800
Methocarbamol85$1,970
Tizanidine Hcl143$1,931
Baclofen185$1,780
Lidocaine14$1,369
Duloxetine Hcl89$1,243
Cyclobenzaprine Hcl123$1,101
Celecoxib23$751
Nortriptyline Hcl52$631
Tramadol Hcl80$552
Diclofenac Sodium27$472
Chlorzoxazone14$398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$536$15,10713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →